文献速递疼痛医学

小胶质细胞在神经病理性疼痛发生机制中的作用

The role of microglia in the pathobiology of neuropathic pain development: what do we know?
PubMed 文献 · Br J Anaesth · 2017-01-01

该综述聚焦小胶质细胞在神经病理性疼痛发生中的作用,指出神经损伤后小胶质细胞被激活,释放Neuregulin-1、MMP-2、MMP-9、CCL2和fractalkine等介质,活化的细胞又释放IL-6、IL-1β和TNF-α等因子增加中间神经元兴奋并降低抑制,从而产生疼痛症状,但确切机制尚未完全阐明。

要点

  • 神经损伤后小胶质细胞激活参与神经病理性疼痛的发生。
  • 小胶质细胞释放IL-6、IL-1β和TNF-α等因子导致疼痛症状。
  • 小胶质细胞与神经元、星形胶质细胞等细胞间存在复杂信号网络。

核心结论

  • 小胶质细胞激活参与神经病理性疼痛的发生和维持,但确切机制尚未完全阐明。

研究设计与样本

  • 综述,未报告检索范围与样本量。

主要发现

  • 神经损伤后释放Neuregulin-1、MMP-2、MMP-9、CCL2和fractalkine等介质参与小胶质细胞激活。
  • 活化的小胶质细胞释放IL-6、IL-1β和TNF-α等因子,增加中间神经元兴奋并降低抑制,导致疼痛症状。

局限性

  • 小胶质细胞产生神经病理性疼痛的确切机制尚未完全阐明。
  • 疼痛介质如何作用于神经元及介质间或神经元-胶质细胞间相互作用仍需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Neuropathic pain, a maladaptive and chronic condition that can develop after a lesion or disease affecting the somatosensory system, is characterized by allodynia, hyperalgesia and spontaneous pain, and comorbidities such as sleep deprivation, depression and anxiety. The activation of microglial cells in response to nerve injury has been implicated in the development of neuropathic pain. Mediators such as Neuregulin-1, matrix metalloproteinase (MMP)-2, MMP-9, The chemokine (C-C motif) ligand 2 (CCL2) and fractalkine are released after nerve injury and are involved in the activation of microglial cells. These activated cells in turn release factors that increase the excitation and decrease the inhibition of interneurons. Microglial cells release factors such as interleukin (IL)-6, IL-1β and tumour necrosis factor-α (TNF-α) that cause the painful symptoms. It is becoming increasingly apparent that an intricate network of cytokines and cellular signalling mechanisms underpin the complex relationship between microglia and various cell types including neurones, astrocytes, oligodendrocytes, mast cells and T-cells. Although the precise mechanism of action of microglial cells in producing neuropathic pain has not been completely elucidated, research into these different activating factors and cytokines is providing further insight into the role of microglial cells in the development and maintenance of neuropathic pain. Further studies also are required to elucidate how "pain" mediators act on neurones and how the interactions between these mediators, or between neurones and glia in the presence of these mediators occur, in order to develop effective therapies for the management of neuropathic pain.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Zhao H, Alam A, Chen Q, et al. The role of microglia in the pathobiology of neuropathic pain development: what do we know? Br J Anaesth. 2017. PMID: 28403399. doi:10.1093/bja/aex006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。